BioCryst Pharmaceuticals Inc. (BCRX)
NASDAQ · Healthcare
BioCryst Pharmaceuticals Inc. Cash on Hand 2009–2025
BioCryst Pharmaceuticals Inc. annual cash on hand history from 2010 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- BioCryst Pharmaceuticals Inc. cash on hand as of December 31, 2025: 89.7M, a 14.30% decrease year-over-year.
- BioCryst Pharmaceuticals Inc. cash on hand for 2025 were 89.7M, a 14.30% decrease from 2024.
- BioCryst Pharmaceuticals Inc. cash on hand for 2024 were 104.7M, a 5.36% decrease from 2023.
- BioCryst Pharmaceuticals Inc. cash on hand for 2023 were 110.6M, a 63.70% decrease from 2022.
- BioCryst Pharmaceuticals Inc. cash on hand for 2022 were 304.8M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| BioCryst Pharmaceuticals Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $90 |
| 2024 | $105 |
| 2023 | $111 |
| 2022 | $305 |
| 2021 | $504 |
| 2020 | $272 |
| 2019 | $114 |
| 2018 | $27 |
| 2017 | $50 |
| 2016 | $22 |
| 2015 | $29 |
| 2014 | $55 |
| 2013 | $21 |
| 2012 | $21 |
| 2011 | $16 |
BioCryst Pharmaceuticals Inc. Cash on Hand — FAQ
BioCryst Pharmaceuticals Inc. (BCRX) cash on hand over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BCRX's cash on hand history?
The chart and table above show BioCryst Pharmaceuticals Inc.'s cash on hand by year and by quarter, including the growth rate.